An overview on drug resistant tuberculosis in India

Paramasivan, C N (1998) An overview on drug resistant tuberculosis in India. Indian Journal of Tuberculosis, 45 (2). pp. 73-81. ISSN 0019-5705

Preview

PDF 199806.pdf - Published Version Download (121kB)

Abstract

Tuberculosis remains one of the major public health problems in India. It has been estimated that about 30% of the world’s tuberculosis patients are residing in India1. Since the control measures for tuberculosis such as BCG vaccination and chemoprophylaxis seem to be unsatisfactory, treatment with anti-tuberculosis drugs becomes inevitable. In recent years, the treatment of tuberculosis has been threatened by the increasing number of patients with drug resistant tuberculosis. Although the phenomenon of drug resistance to Mycobacterium tuberculosis was observed even in the early days of streptomycin usage, the current threat is due to the emergence of strains resistant to the potent bactericidal anti-tuberculosis drugs such as isoniazid and rifampicin which are used in the tuberculosis control programmes.

Item Type:	Article
Subjects:	Tuberculosis > Laboratory Research > Bacteriological
Divisions:	Basic Science Research > Bacteriology
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	30 Oct 2013 04:40
Last Modified:	14 Mar 2016 04:28
URI:	http://eprints.nirt.res.in/id/eprint/463

Actions (login required)

View Item